Third Biennial Symposium on Age Related Macular Degeneration

第三届年龄相关性黄斑变性双年研讨会

• 批准号: 8783667
• 负责人: Patricia Ann D'Amore
• 金额: $ 2万
• 依托单位: SCHEPENS EYE RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8783667
• 关键词: Address; Adverse effects; Age related macular degeneration; Aging; American; Animal Model; Area; Award; Basic Science; Biology; Biotechnology; Blindness; Cardiovascular Diseases; Caring; Cell Transplantation; Chronic; Collaborations; Communication; Developed Countries; Development; Disabled Persons; Disease; Ear; Epidemic; Epithelial; Eye; Fertilization; Funding; Funding Applicant; Goals; Image; Individual; Inflammation; Investigation; Light; Lipids; Metabolism; MicroRNAs; Natural regeneration; Neurodegenerative Disorders; Ophthalmology; Pathogenesis; Pathology; Pharmacologic Substance; Prevalence; Quality of life; Research; Research Institute; Research Personnel; Retinal; Retinal Pigments; Risk; Schedule; Science; Scientist; Senior Scientist; Specialist; Stress; Structure of retinal pigment epithelium; Time; Travel; Underrepresented Minority; Vision; aging population; base; bevacizumab; cost; demographics; design; experience; graduate student; insight; interest; medical schools; meetings; multidisciplinary; neuroprotection; novel; prevent; programs; public health relevance; success; symposium; virtual

DESCRIPTION (provided by applicant): Funds are requested to support The Third Biennial Symposium on Age-related Macular Degeneration (AMD) to be held October 23 & 25, 2014 in the Starr Center for Scientific Communications at the Schepens Eye Research Institute (SERI). The meeting is co-organized by Drs. Patricia A. D'Amore, Director of Research at SERI, Mass Eye and Ear (MEE); Dr. Ivana Kim, a retinal specialist at MEE; and, Dr. Joan Miller Chief of Ophthalmology at MEE and Chair of the Department of Ophthalmology at Harvard Medical School. This meeting will build on the strong successes of the first and second biennial meetings that were held in September 2010 and September 2012, respectively. AMD is the leading cause of irreversible blindness in industrialized countries in people 50 years or older. More than eight million Americans have AMD, and as a result of the aging population, the prevalence of AMD is expected to increase by more than 50% by the year 2020. In light of these demographics, the incomplete understanding of the pathogenesis of AMD makes this a timely and important meeting. The goal of this conference is to stimulate discussion and collaborations aimed at elucidating the mechanisms that underlie the development of AMD and, thus, to identify means to treat, cure, and ultimately prevent AMD. This meeting will be distinct from other meetings on AMD in its format, which allows significant time for discussion. An additional unique feature is the inclusion of speakers who will highlight the parallels between AMD and other systemic manifestations of aging such as cardiovascular disease, lipid biology, and other neurodegenerative diseases. Dr. Joan Miller, a leader in the field, will present the Keynote address, and Dr. Robert D'Amato will deliver a summary and concluding remarks. Topics to be covered include: retinal pigment epithelial cell transplantation, retinal and choroidal vasculatures, inflammation, new concepts in pathology (ER stress, microRNAs in disease, metabolism), retinal pigment epithelial biology, neuroprotection and regeneration, imaging, and animal models. Travel awards will be provided to attract graduate students and fellows, with a particular emphasis on under-represented minorities and persons with disabilities.

描述（由申请人提供）：要求资金支持将于2014年10月23日至25日在Schepens Eye Research Institute（Seri）的Starr Scientific Communication Center（SERI）举行的第三次双年两年一次的黄斑变性（AMD）。会议由Drs共组织。 Seri，Mass Eye and Ear研究总监Patricia A. D'Amore（MEE）； MEE的视网膜专家Ivana Kim博士；以及MEE琼·米勒（Joan Miller）眼科主任，哈佛医学院的眼科部主席。这次会议将基于分别于2010年9月和2012年9月举行的第一和第二个双年展会议的巨大成功。 AMD是50岁以上工业化国家不可逆失明的主要原因。超过800万的美国人拥有AMD，由于人口老龄化，AMD的患病率预计到2020年将增加50％以上。鉴于这些人口统计数据，对AMD发病机理的不完全了解使这一及时而重要。这次会议的目的是刺激旨在阐明AMD发展的机制的讨论和协作，从而确定治疗，治愈和最终防止AMD的方法。这次会议将与AMD格式的其他会议不同，这为讨论提供了大量时间。另一个独特的特征是说话者将重点介绍AMD与其他衰老的系统性表现之间的相似之处，例如心血管疾病，脂质生物学和其他神经退行性疾病。该领域的领导者琼·米勒（Joan Miller）博士将介绍主题演讲，罗伯特·阿马托（Robert D'Amato）博士将发表摘要和结论。要涵盖的主题包括：视网膜色素上皮细胞移植，视网膜和脉络膜血管，炎症，病理学中的新概念（ER应激，疾病中的microRNA，代谢），视网膜色素上皮生物学，神经保护和再生和再生，成像以及动物模型。将提供旅行奖，以吸引研究生和研究员，特别着重于代表性不足的少数民族和残疾人。